Chen C - Search Results

1

[Construction and expression of human-mouse chimeric antibody against human CD40].

Qu QX, Chen YJ, Ge Y, Wang Q, Chen C, Yang MF, Zhang XG. Qu QX, et al. Among authors: chen yj, chen c. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Mar;22(2):189-92. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006. PMID: 16507256 Chinese.

2

Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells.

Chen C, Qu QX, Huang JA, Zhu YB, Ge Y, Wang Q, Zhang XG. Chen C, et al. Immunobiology. 2007;212(3):159-65. doi: 10.1016/j.imbio.2007.01.004. Epub 2007 Mar 23. Immunobiology. 2007. PMID: 17412283

3

[Expression of human-mouse chimeric antibody against CD40 in CHO cell line and characterization of its function].

Qu QX, Chen C, Wang Q, Ge Y, Chen YJ, Qiu YH, Zhang XG. Qu QX, et al. Among authors: chen yj, chen c. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Jun;23(6):565-8. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007. PMID: 17553357 Chinese.

4

[Therapeutic effect of agonistic CD40 monoclonal antibody combined with CTL on hu-SCID mouse B lymphoma model].

Zhou H, Xi H, Ma QR, Chen C, Zhang F, Zhang XG, Gu ZJ. Zhou H, et al. Among authors: chen c. Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):181-5. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17649632 Chinese.

5

Fine-tuned expression of programmed death 1 ligands in mature dendritic cells stimulated by CD40 ligand is critical for the induction of an efficient tumor specific immune response.

Gu T, Zhu YB, Chen C, Li M, Chen YJ, Yu GH, Ge Y, Zhou SY, Zhou H, Huang Y, Qiu YH, Zhang XG. Gu T, et al. Among authors: chen yj, chen c. Cell Mol Immunol. 2008 Feb;5(1):33-9. doi: 10.1038/cmi.2008.4. Cell Mol Immunol. 2008. PMID: 18318992 Free PMC article.

6

CD40-activated apoptotic tumor cell-pulsed dendritic cell could potentially elicit antitumor immune response: involvement of up-regulation of B7-H3 expression.

Chen C, Zhu YB, Qu QX, Ge Y, Huang JA, Wang Y, Zhang XG. Chen C, et al. J Immunother. 2009 Jan;32(1):29-35. doi: 10.1097/CJI.0b013e31818c8816. J Immunother. 2009. PMID: 19307991

7

Preparation and characterization of a novel chimeric antibody against human CD40 with the potential to inhibit Daudi cell proliferation.

Qu QX, Ge Y, Chen YJ, Chen C, Qiu YH, Zhang XG. Qu QX, et al. Among authors: chen yj, chen c. Hybridoma (Larchmt). 2009 Apr;28(2):121-8. doi: 10.1089/hyb.2008.0081. Hybridoma (Larchmt). 2009. PMID: 19382845

8

Inhibition of lung cancer cell proliferation by CD40 signaling through tumor necrosis factor I.

Lu XD, Zhu XL, Chen C, Zhang GB, Zhang XG, Huang JA. Lu XD, et al. Among authors: chen c. Ai Zheng. 2009 Jan;28(1):20-3. Epub 2009 Jan 12. Ai Zheng. 2009. PMID: 19448410 Free article.

9

High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation.

Mu CY, Huang JA, Chen Y, Chen C, Zhang XG. Mu CY, et al. Among authors: chen c, chen y. Med Oncol. 2011 Sep;28(3):682-8. doi: 10.1007/s12032-010-9515-2. Epub 2010 Apr 6. Med Oncol. 2011. PMID: 20373055

10

[The Expression and Biological Significance of PD-L1 on Lung Cancer Cell Lines.].

Chen C, Mu C, Qu Q, Zhu Y, Sun J, Zhang X, Huang J. Chen C, et al. Zhongguo Fei Ai Za Zhi. 2009 Aug 20;12(8):859-63. doi: 10.3779/j.issn.1009-3419.2009.08.05. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719171 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91,383 results

Search Page

Filters